What Leva Capital does

Leva Capital is a Toronto-based healthcare venture capital firm that invests in privately owned Canadian MedTech and Digital Health companies from startups through medium-sized businesses, with stated focus on pre-seed, seed, and Series A rounds. Founded in 2020 and operating as a privately held entity under the legal name Leva Financial Corp., the firm is registered in Canada and headquartered at 637 College Street, Suite 201, Toronto. Leva explicitly markets itself as a "value-added investor," pairing equity capital with structured hands-on support across regulatory guidance, intellectual property strategy, and commercialization — areas identified as chronic pain points for early-stage healthcare ventures facing a "growing gap in early-growth capital." Its geographic footprint is single-country/domestic (Canada) with no current international operations disclosed.

The firm's product surface consists of two offerings: (i) Leva Capital Fund II, a healthcare-focused investment fund deploying equity into pre-seed, seed, and Series A MedTech and Digital Health startups; and (ii) the Leva Capital Accelerator Program, a 3-6 month structured program that selects 4-5 pre-seed ventures per cohort annually and provides customized curriculum, group mentoring, 1-1 advisor sessions, and pitch deck and data room support, with Leva Fund II taking small equity compensation in exchange. Revenue is generated through two streams — equity investment returns from portfolio companies (carry/exits) and accelerator equity stakes — and no customer-facing pricing is disclosed. The current disclosed portfolio of 12 companies spans medical devices (Arbutus Medical, COSM Medical, Realize Medical), diagnostics (Qualisure Diagnostics, FluidAI), digital health platforms (EmergConnect, iApotheca, ManagingLife, Neurovine), and consumer health (All Skin, Eli, LUCID). Go-to-market is sales-led, driven by direct outreach, inbound inquiries via a website contact form and [email protected], and referrals through the team's Canadian healthcare network.

The firm is co-founded by Eddie Gobran (Managing Partner; BASc Chemical Engineering, University of Waterloo; MBA Finance, McMaster) and Matt Girgis (Managing Director of Volvo Car Canada; BBA Finance and Accounting, Schulich School of Business), supported by Investment Associate Aidan Harris and a large advisory bench that includes former Scotiabank MD Murray Neal (Investment Review Committee), BioWare co-founder and Order of Canada member Dr. Ray Muzyka, physician-entrepreneur Dr. Brent Norton (ex-PreMD, Novadaq), regulatory expert Jafar Shenasa (former FDA Center of Excellence Digital Health Advisor), IP strategist Dr. Stephen Leonard (Aird & McBurney), and other operators across biotech, IoT, finance, and marketing. Headcount is reported at 1-10 employees, and the firm is not a technology company — it operates on traditional venture capital economics (committed capital from LPs, equity stakes, exits) rather than software ARR.

Name

Leva Capital

Legal name

Leva Financial Corp.

Website

https://levacapital.ca

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Leva Capital is a Toronto-based healthcare venture capital firm that invests in Canadian MedTech and Digital Health startups from pre-seed through Series A. It combines equity investment via Fund II with hands-on regulatory, IP, and commercialization support through a 3-6 month accelerator program.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

Keywords

• Healthcare venture capital
• MedTech investing
• Digital Health investment
• Startup accelerator
• Pre-seed funding

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Investment Returns: Leva Capital generates returns through equity investments in early-stage healthcare startups. As a value-added investor, the firm provides capital in exchange for equity stakes, with the expectation of returns through exits or follow-on funding rounds.
2. Accelerator Program Equity Compensation: Leva Fund II receives small equity compensation from startups participating in the Leva Accelerator Program in exchange for the 3-6 month accelerator curriculum, mentorship, pitch deck support, and data room assistance.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Leva Capital is a Toronto-based healthcare venture capital firm that invests in early-stage privately owned MedTech and Digital Health startups across Canada, from pre-seed and seed rounds through Series A. The firm provides equity capital alongside hands-on value-added support including regulatory guidance, intellectual property strategy, and commercialization assistance. Leva Capital also operates the Leva Accelerator Program, a 3-6 month curriculum that selects 4-5 pre-seed ventures per cohort annually and invests in graduates.

Product overview

Leva Capital is a healthcare venture capital firm operating as a single unified investment offering rather than a platform-plus-modules architecture. The firm provides venture capital investment services and operates the Leva Capital Accelerator Program. Their investment strategy focuses on MedTech and Digital Health startups at pre-seed, seed, and Series A stages, offering not only financial backing but also hands-on support across regulatory guidance, intellectual property strategy, and commercialization. The accelerator program is a 3-6 month customized curriculum with mentorship, selecting 4-5 ventures per cohort per year.

Differentiator

Problem solved

Functional benefit

Products and services

• Leva Capital Fund II Healthcare-focused venture capital fund that provides equity investment to early-stage MedTech and Digital Health startups in Canada at pre-seed, seed, and Series A rounds. The fund pairs capital with hands-on value-added support including regulatory guidance, intellectual property strategy, and commercialization assistance. Targeted at founders of healthcare startups whose solutions improve healthcare systems, patient outcomes, or access to healthcare.
• Leva Accelerator Program A 3-6 month accelerator program tailored to pre-seed healthcare ventures that delivers a customized curriculum with group mentoring, 1-1 advisor sessions, pitch deck and data room support, and culminates in an investment from Leva Fund II upon graduation. The program selects 4-5 ventures per cohort annually and Leva Fund II receives small equity compensation in exchange for the program. Targeted at earliest-stage healthcare founders who need structured preparation before institutional investment.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Real Ventures: Montreal-based early-stage Canadian venture capital firm with a broad tech mandate but meaningful healthcare exposure. A larger, more established Canadian VC that competes for some of the same early-stage healthcare deals.
• Inovia Capital: Montreal-based Canadian venture capital firm investing across software, consumer, and healthcare at early and growth stages. A larger, well-capitalized Canadian VC with healthcare exposure, often competing for the same later-seed/Series A deals Leva targets.

Direct peers

• Lumira Ventures: Canadian healthcare-dedicated venture capital firm investing across therapeutics, medical devices, and digital health. Competes head-to-head with Leva for Canadian early-stage healthcare deals and shares a similar geographic and sector focus.
• Genesys Capital: Toronto-based Canadian venture capital firm focused on early-stage and growth-stage healthcare and life sciences companies. Direct competitor for Canadian MedTech/Digital Health deals at the same stages Leva targets.
• Framework Venture Partners: Toronto-based Canadian VC firm with a healthcare/tech focus, investing in early-stage Canadian startups. Similar geographic concentration and stage profile to Leva, with overlapping deal flow.
• iGan Partners: Toronto-based Canadian venture capital firm dedicated to early-stage MedTech and Digital Health investments. Directly comparable mandate, stage focus, and Canadian geographic footprint to Leva Capital.
• AmorChem: Montreal-based Canadian venture capital firm focused on life sciences and healthcare innovation, including therapeutics, MedTech, and digital health. Targets Canadian academic spinouts and early-stage ventures, closely overlapping Leva's thesis.

Others

• Maple Leaf Angels: Toronto-based Canadian angel investor network with active healthtech deal flow; Murray Neal (Leva's Investment Review Committee member) sits on its board. Functions as a complementary capital source and referral channel rather than a direct competitor.
• Creative Destruction Lab: Toronto-based seed-stage program for massively scalable science-based startups; Leva's co-founder mentors through CDL and several team members serve as CDL mentors. Functions as a feeder of healthcare startups into Canadian VC funds including Leva.

Emerging players

• ThresholdImpact: Canadian impact-focused venture firm investing in healthtech, medtech, biotech, and deep tech, founded by Dr. Ray Muzyka — a current Leva Capital advisor. Strong thematic and personnel overlap with Leva's healthcare-and-impact thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles22 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leva Capital